thanks jcurvewow finally an informed hc contributor writing down...

thanks jcurve
wow finally an informed hc contributor
writing down communication thats
sensibily presented and , informed ! !!
once phase 11 non toxic trial finished as per now against all time iv trials required by tga fda etc and plasma levels assessed as being in efficacy range - data shortly - the co can seek clearance for dosage under hospital protocol guidance to administer recce 327 or other higher concentrate product to sick patients
most likely decisions by authorities on this forthcoming v soon
shorter time iv admin iv to let gps undertake first in line immediate defence for patients exhibiting infection issues in their local premises as first attack against bacteriological infection - ie importantly - without waiting days for gel growth micro analysis to determine type and possible amr pathogen infections

timing of urgent administration critical in dealing with sepsis
hours not days

recce in prime spot for this - no other co or product anywhere near this product solution to the serious unmet medical need
Indonesians in collaboration now ? Expect news shortly i expect of commencement of applications of recce 327 gel to infected diabetic ulcer patients then next step - infected and sick sepsis patients
all these processes and trials need to follow protocols to the letter and are closely recorded and monitored and data collected
this exasperatingly takes time
but no issues other than total success have been observed in tga approved infected patients or trial healthy subjects ( co horts) as regulated as compulsory

please report facts not irresponsible speculations or thiose with agendas with smear campaigns